Posts tagged reports
Yandex Reports Mixed Earnings For Q4
Feb 22nd
Yandex (NASDAQ:YNDX) reported EPS of $0.20, better than analyst estimates of $0.18 per share. Revenues for the quarter were $200 million, missing consensus estimates of $207.58 million.
Arkady Volozh, Chief Executive Officer of Yandex said, “Yandex demonstrated strong traffic and revenue growth, capping off results for 2011 at the top end of our guidance range and building upon our clear leadership in the Russian search market. During the past year we continued to innovate and offer new services that make a difference in the lives of our users, including those in Turkey, our first market outside the CIS. This past year’s significant investments in talent and infrastructure, along with our focus on the needs of users, position us well going forward. We will continue to develop a broad range of services that complement our core search platform, including maps and personal services on the desktop and on mobile platforms, emphasizing collaboration with our strategic partners.”
Yahoo Shareholder Blasts Current Board
Feb 17th
Yahoo shareholder Dan Loeb blasted the current board line-up of the
company. What did he suggest? Well, that they appoint him to the
board.
Loeb runs an activist hedge fund, Third Point, and this isn’t unusual
- he’s a regular critic of Yahoo’s company’s management.
He weighed in on the recent departures of co-founder Jerry Yang and
Board Chairman Roy Bostock on Tuesday, recommending some new directors
in a filing with the Securities and Exchange Commission.
In addition to himself, he also suggested former NBC Universal boss
Jeff Zucker and former MTV President Michael Wolf.
Top Hedge Fund Managers Invest in Apple
Feb 17th
Top hedge fund managers including David Tepper, Andreas Halvorsen and
David Einhorn smartly added to their holdings of Apple in the fourth
quarter after the death of Steve Jobs.
Their stakes have likely provided a quick pay-off.
Shares of Apple are up 26 percent this year. Apple posted spectacular
quarterly results on January 24th, and in the weeks that followed,
its shares have surged to over $500.
Zale Shares Pop 5.4% On Signet Buyout Speculation
Feb 16th
Zale (NYSE:ZLC) shares are trading 5.4% higher premarket on speculation that the jeweler could prosper in a merger with its larger competitor Signet (NYSE:SIG).
One investment banker told Reuters yesterday evening. “The Zale name has taken a beating, but it’s still a brand that people know. Signet is more skilled at marketing, so with them at the helm at Zale, it could become a prominent name again.”
The Reuters article said that Signet could afford to pay $5 – $6 per share, or approximately $161 million – $193 million, and still have the deal adding to its EPS after the 1st year.
Wal-Mart Selects Quintiq For Supply Chain Optimization
Feb 15th
Quintiq announced today that Wal-Mart Stores (NYSE:WMT) chose Quintiq to provide a next-generation load assignment and dispatch system designed to lower the total miles driven and improve the efficiency of the retailer’s U.S. fleet.
Victor Allis, CEO of Quintiq says: “We are delighted with Walmart’s choice of Quintiq. We believe this demonstrates that no supply chain is too large or complex for our state-of-the-art Supply Chain Optimization software.”
Wal-Mart Stores (NYSE:WMT) has potential upside of 0.9% based on a current price of $62 and an average consensus analyst price target of $62.56.
Apple Works With Component Supplier To Test New Smaller Screen iPad
Feb 14th
Apple (NASDAQ:AAPL) is working with component suppliers in Asia in order to test a new tablet computer with a smaller screen, according to a Wall Street Journal report.
Unnamed officials at some Apple suppliers say the company has shown them designs for a new device with a screen size of about 8 inches, and say it is qualifying suppliers for it.
The current Apple model, the iPad 2, sports a 9.7-inch screen.
This news comes after Apple reached a milestone yesterday, surpassing the $500 threshold, finishing at $502. The stock is up 19% since posting its December quarter results this past January.
Hospira Tops Estimates As Top Line Rises 2.2%
Feb 14th
Hospira (NYSE:HSP) reported Q4 EPS of $0.51, topping estimates by $0.04.
Revenues in the quarter rose 2.2% to $1.01 billion.
F. Michael Ball, chief executive officer said, “While 2011 was a challenging year as a result of our quality transformation efforts, we met our revised financial expectations, generating over $4 billion in sales, and advanced our remediation efforts. We made significant progress on many fronts during the year, including the launch in the United States of two important oncolytic products and an anti-infective drug, as well as initiating the Phase III U.S. clinical program for our biosimilar erythropoietin. We remain firmly committed to reinforcing our foundation and instilling a culture of high quality throughout the organization, actions we believe will create a strong competitive advantage for Hospira and position us for sustainable, long-term growth and increased shareholder value.”
Hospira is currently above its 50-day moving average (MA) of $31.52 and should find resistance at its 200-day MA of $41.54.
Lorillard Tops Estimates For Q4, Rose 10.3% Year-Over-Year
Feb 9th
Lorillard (NYSE:LO) reported Q4 EPS of $2.20, better than analyst estimates of $1.95 per share. Revenues for the quarter rose 10.3% year-over-year to $1.61 billion, better than consensus estimates of $1.08 billion. Murray S. Kessler, Chairman, CEO & President said, “Lorillard had an outstanding fourth quarter which helped the Company once again post record sales and profit for the full year of 2011. Fourth quarter gains in market share, pricing realization and margins resulting from the Company’s strategic initiatives implemented during 2011 all contributed to the strong quarter and year.” Lorillard (NYSE:LO) has potential upside of 7.6% based on a current price of $113.36 and an average consensus analyst price target of $122.
Bunge Tops Estimates And Offers Capex And Milling Outlook
Feb 9th
Bunge (NYSE:BG) reported Q4 EPS of $1.65, beating estimates of $1.57. Revenues in the quarter rose 29.2% year-over-year to $16.4 billion, topping estimates by $13.73 billion. Alberto Weisser, Bunge’s Chairman and Chief Executive Officer stated, “In 2011 Bunge produced strong results in many parts of our business, but faced significant headwinds in others. On a combined basis, our agribusiness, edible oils and milling segments generated record full-year results of over $1.1 billion. However, reduced sugarcane production yields in Brazil due to back-to-back years of poor weather had a material impact on volumes in our sugar & bioenergy segment.” Bunge (NYSE:BG) has potential upside of 18.8% based on a current price of $59.74 and an average consensus analyst price target of $71.
Moody’s Reports Mixed Earnings For Q4
Feb 8th
Moody’s (NYSE:MCO) reported EPS of $0.43, missing analyst estimates of $0.48 per share. Revenues for the quarter rose 0.5% year-over-year to $567.00, better than analyst estimates of $558.55 million.
Raymond McDaniel, Chairman and Chief Executive Officer of Moody’s said, “Moody’s achieved strong performance for full-year 2011, with growth in all lines of business at both Moody’s Investors Service and Moody’s Analytics despite volatile business conditions. For 2012, we anticipate revenue growth across most areas of our business and earnings per share in the range of $2.62 to $2.72.”
Moody’s (NYSE:MCO) has potential upside of 5.2% based on a current price of $38.98 and an average consensus analyst price target of $41.
